STOCKHOLDERS' EQUITY

12 Months Ended

Dec. 31, 2020

Dec. 31, 2019

Stockholders' Equity Note [Abstract]

STOCKHOLDERS' EQUITY

NOTE 7 – STOCKHOLDERS' EQUITY

Series A Preferred Stock

Liquidation Preference 

In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Corporation, holders of shares of Series A Preferred Stock shall not be entitled to any liquidation preference.

Voting

On any matters presented to the stockholders of the corporation for their action or consideration at any meeting of stockholders of the Corporation (or by written consent of stockholders in lieu of meeting), each holder of outstanding shares of Series A Preferred Stock shall be entitled to vote in an amount equal to 1,000 votes per share. Series A Preferred Stock shall vote as a single class and such voting rights shall be identical in all respects.

Conversion

The holders of the shares of Series A Preferred Stock shall not have any rights hereunder to convert such shares into, or exchange such shares for, shares of any other series or class of capital stock of the Corporation or of any other person.

Common stock

The holders of our common stock are entitled to the following rights:

Voting

Each share of our common stock entitles its holder to one vote per share on all matters to be voted or consented upon by the stockholders. Holders of our common stock are not entitled to cumulative voting rights with respect to the election of directors.

Dividend

Subject to limitations under Delaware law and preferences that may apply to any shares of preferred stock that we may decide to issue in the future, holders of our common stock are entitled to receive ratably such dividends or other distributions, if any, as may be declared by our Board out of funds legally available.

Liquidation

In the event of the liquidation, dissolution, or winding up of our business, the holders of our common stock are entitled to share ratably in the assets available for distribution after the payment of all of our debts and other liabilities, subject to the prior rights of the holders of our preferred stock.

Other Matters

The holders of our common stock have no subscription, redemption, or conversion privileges. Our common stock does not entitle its holders to preemptive rights. All of the outstanding shares of our common stock are fully paid and non-assessable. The rights, preferences and privileges of the holders of our common stock are subject to the rights of the holders of shares of any series of preferred stock which we may issue in the future.

Reverse Stock Split

In June of 2020, we effected a 5:1 reverse stock split (the “Reverse Stock Split”) by filing an amendment to the Company’s Amended and Restated Certificate Incorporation with the Delaware Secretary of State. The Reverse Stock Split combined every five shares of Common Stock issued and outstanding immediately prior to effecting the Reverse Stock Split into one share of Common Stock. As a result, the number of issued and outstanding shares of Common Stock was retroactively adjusted in the consolidated financial statements.

2020 Incentive Plan

On March 31, 2020, the Company adopted the Applied UV, Inc. 2020 Omnibus Incentive Plan (the “Plan”) with 600,000 shares of common stock available for issuance under the terms of the Plan. The Plan permits the granting of Nonqualified Stock Options, Incentive Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Shares, Performance Units and Other Awards. The objectives of the Plan are to optimize the profitability and growth of the Company through incentives that are consistent with the Company’s goals and that link the personal interests of Participants to those of the Company’s stockholders. The Plan is further intended to provide flexibility to the Company in its ability to motivate, attract and retain the services of Participants who make or are expected to make significant contributions to the Company’s success and to allow Participants to share in the success of the Company. From time to time, we may issue Incentive Awards pursuant to the Plan. Each of the awards will be evidenced by and issued under a written agreement.

If an incentive award granted under the Plan expires, terminates, is unexercised or is forfeited, or if any shares are surrendered to us in connection with an incentive award, the shares subject to such award and the surrendered shares will become available for future awards under the Plan. The number of shares subject to the Plan, and the number of shares and terms of any Incentive Award may be adjusted in the event of any change in our outstanding common stock by reason of any stock dividend, spin-off, stock split, reverse stock split, recapitalization, reclassification, merger, consolidation, liquidation, business combination or exchange of shares, or similar transaction.

There are 462,500 shares available for future grants under the plans.

A summary of the Company’s option activity and related information follows:

	Number of Shares			Option Price Per Share		Weighted-Average Exercise Price
Options Outstanding at January 1, 2020		—		$	—	$	—
Granted		137,500		$	4.97	$	4.97
Expired/cancelled		(750	)
Options Outstanding, December 31, 2020		136,750		$	4.97	$	4.97
Options exercisable, December 31, 2020		6,125		$	5.00	$	5.00

Share-based compensation expense for options totaling $15,049 was recognized in our results for the year ended December 31, 2020 based on awards vested. There was no option activity prior to December 31, 2019.

The valuation methodology used to determine the fair value of the options issued during the year was the Black-Scholes option-pricing model. The Black-Scholes model requires the use of a number of assumptions including volatility of the stock price, the average risk-free interest rate, and the weighted average expected life of the options.

The risk-free interest rate assumption is based upon observed interest rates on zero coupon U.S. Treasury bonds whose maturity period is appropriate for the term of the options.

Estimated volatility is a measure of the amount by which the Company’s stock price is expected to fluctuate each year during the expected life of the award. The Company’s calculation of estimated volatility is based on historical stock prices of these peer entities over a period equal to the expected life of the awards. The Company uses the historical volatility of peer entities due to the lack of sufficient historical data of its stock price.

As of December 31, 2020, there was $307,459 of total unrecognized compensation expense related to unvested employee options granted under the Company’s share-based compensation plans that is expected to be recognized over a weighted average period of approximately 1 year.

The weighted average fair value of options granted, and the assumptions used in the Black-Scholes model during the year ended December 31, 2020 are set forth in the table below.

	2020
Weighted average fair value of options granted	$	4.97
Risk-free interest rate		0.28-0.37%
Volatility		41.4-51.45%
Expected life (years)		5.50
Dividend yield		0.00	%

Common Stock Warrants

A summary of the Company’s warrant activity and related information follows:

	Number of Shares		Option Price Per Share		Weighted-Average Exercise Price
Warrants Outstanding at January 1, 2020		—	$	—	$	—
Granted		85,000	$	5.00	$	5.00
Expired		—
Warrants Outstanding, December 31, 2020		85,000	$	5.00	$	5.00
Warrants exercisable, December 31, 2020		85,000	$	5.00	$	5.00

Share-based compensation expense for warrants totaling $100,896 was recognized in our results for the year ended December 31, 2020 based on awards vested.

The valuation methodology used to determine the fair value of the warrants issued during the year was the Black-Scholes option-pricing model. The Black-Scholes model requires the use of a number of assumptions including volatility of the stock price, the average risk-free interest rate, and the weighted average expected life of the warrants.

The risk-free interest rate assumption is based upon observed interest rates on zero coupon U.S. Treasury bonds whose maturity period is appropriate for the term of the warrants.

Estimated volatility is a measure of the amount by which the Company’s stock price is expected to fluctuate each year during the expected life of the award. The Company’s calculation of estimated volatility is based on historical stock prices of these peer entities over a period equal to the expected life of the awards. The Company uses the historical volatility of peer entities due to the lack of sufficient historical data of its stock price.

As of December 31, 2020, there was no unrecognized compensation expense related to unvested warrants granted under the Company’s share-based compensation plans.

The weighted average fair value of warrants granted, and the assumptions used in the Black-Scholes model during the year ended December 31, 2020 are set forth in the table below.

	2020
Weighted average fair value of options granted	$	5.00
Risk-free interest rate		0.37-0.89%
Volatility		36.5-41.4%
Expected life (years)		2.50
Dividend yield		0.00	%

During the period August 31, 2020 through September 3, 2020, the Company closed on an initial public offering (the “Offering”) in which it sold 1,150,000 shares of common stock (which included the exercise of an over-allotment option to purchase 150,000 shares of common stock) at a public offering price of $5.00 per share. In connection with the Offering, the Company received $5,750,000 less underwriting fees of $517,500 and write-off of capitalized IPO costs in the amount of $341,145, resulting in net proceeds of $4,891,355. The shares were offered and sold to the public pursuant to the Company’s registration statement on Form S-1, which was declared effective by the Securities and Exchange Commission on August 28, 2020. Additionally, the Company issued 161,794 shares to Carmel, Milazzo & Feil LLP as partial consideration for legal services in connection with the Offering.

On November 13, 2020, the Company closed on a second public offering (the “Second Offering”) in which it sold 1,401,905 shares of common stock (which included the exercise of an over-allotment option to purchase an additional 182,857 shares of common stock) at a public offering price of $5.25 per share. In connection with the Second Offering, the Company received $7,360,000 less underwriting fees of $625,600 and write-off of public offering costs in the amount of $316,246, resulting in net proceeds of $6,418,155.

Restricted Stock Awards

We record compensation expense for restricted stock awards based on the quoted market price of our stock at the grant date and amortize the expense over the vesting period. The company did not grant any restricted stock awards in 2019.

In July of 2020, the company granted 230,083 restricted stock awards. Of these awards, 127,583 vest quarterly over an 18 month period with the first date of vesting beingSeptember 30, 2020. As of December 31, 2020, 42,528 of these restricted stock awards were vested. The fair market value of these awards was $5 per share and the company expensed $212,638 of stock based compensation related to these awards during the year ended December 31, 2020.

On July 9, 2020, 62,500 restricted stock awards were granted. The restricted stock awards vest in full on January 1, 2021. As of December 31, 2020, none of the restricted stock awards were vested. The fair market value of these awards was $5 per share and the company expensed $312,500 of stock based compensation related to these awards during the year ended December 31, 2020.

On July 9, 2020, 40,000 restricted stock awards were granted. The restricted stock awards vest evenly over a four year period with the first vesting to occur on January 1, 2021. As of December 31, 2020, none of these restricted stock awards were vested. The fair market value of these awards was $5 per share and the company expensed $25,000 of stock based compensation related to these awards during the year ended December 31, 2020.

NOTE 7 - STOCKHOLDERS' EQUITY

Series A Preferred Stock

Liquidation Preference

In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Corporation, holders of shares of Series A Preferred Stock shall not be entitled to any liquidation preference.

Voting

On any matters presented to the stockholders of the corporation for their action or consideration at any meeting of stockholders of the Corporation (or by written consent of stockholders in lieu of meeting), each holder of outstanding shares of Series A Preferred Stock shall be entitled to vote in an amount equal to 1,000 votes per share. Series A Preferred Stock shall vote as a single class and such voting rights shall be identical in all respects.

Conversion

The holders of the shares of Series A Preferred Stock shall not have any rights hereunder to convert such shares into, or exchange such shares for, shares of any other series or class of capital stock of the Corporation or of any other person.

Common stock

The holders of our common stock are entitled to the following rights:

Voting

Each share of our common stock entitles its holder to one vote per share on all matters to be voted or consented upon by the stockholders. Holders of our common stock are not entitled to cumulative voting rights with respect to the election of directors.

Dividend

Subject to limitations under Delaware law and preferences that may apply to any shares of preferred stock that we may decide to issue in the future, holders of our common stock are entitled to receive ratably such dividends or other distributions, if any, as may be declared by our Board out of funds legally available.

Liquidation

In the event of the liquidation, dissolution, or winding up of our business, the holders of our common stock are entitled to share ratably in the assets available for distribution after the payment of all of our debts and other liabilities, subject to the prior rights of the holders of our preferred stock.

Other Matters

The holders of our common stock have no subscription, redemption, or conversion privileges. Our common stock does not entitle its holders to preemptive rights. All of the outstanding shares of our common stock are fully paid and non-assessable. The rights, preferences and privileges of the holders of our common stock are subject to the rights of the holders of shares of any series of preferred stock which we may issue in the future.